The effects of implementation of guideline-directed medical therapy on relief of angina in patients with stable coronary artery disease in Serbia

The effects of implementation of guideline-directed medical therapy on relief of angina in patients with stable coronary artery disease in Serbia

Introduction. Adherence to proposed lifestyle changes and prescribed medication in patients with stable coronary artery disease (SCAD) is poor. Objective. We sought to investigate the influence of adjusting guideline proposed medications on relief of angina in a large group of patients with...

Full description

Bibliographic Details
Main Authors:	Ilić Ivan, Stanković Ivan, Janićijević Aleksandra, Kušić Jovana, Vidaković Radosav, Otašević Petar, Andrić Vesna, Poznanović Snežana, Petrović Ivana, Burazor Ivana, Ristić Arsen, Ilić Stevan, Benc Dragan, Davidović Goran, Stojković Gabrijela, Putniković Biljana, Nešković Aleksandar N.
Format:	Article
Language:	English
Published:	Serbian Medical Society 2016-01-01
Series:	Srpski Arhiv za Celokupno Lekarstvo
Subjects:	stable coronary artery disease guidelines medical therapy trimetazidine
Online Access:	http://www.doiserbia.nb.rs/img/doi/0370-8179/2016/0370-81791612590I.pdf

Similar Items

Efficacy of Trimetazidine and Sulodexide in Patients with Microvascular Angina
by: S. A. Boldueva, et al.
Published: (2020-07-01)

CLINICAL EFFECTIVENESS OF THE MODIFIED RELEASE TRIMETAZIDINE IN MICROVASCULAR ANGINA
by: P. Yu. Galin, et al.
Published: (2016-12-01)

TRIMETAZIDINE ADDITION TO ANTIANGINAL THERAPY: EFFECTS ON EFFICACY AND QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA TREATED OUTPATIENTLY
by: M A Shalenkova
Published: (2012-04-01)

Triple antianginal combinations in the treatment of elderly and senile patients with stable angina
by: S G Kanorskii, et al.
Published: (2016-12-01)

The effectiveness of trimetazidine and fabomotizole in the prevention of angina progression and improvement of life quality in patients in area of armed conflict
by: Z. Yu. Shakhbiyeva, et al.
Published: (2019-03-01)

Evaluation of the efficiency of combined pharmacotherapy with the use of trimetazidine with prolonged release in patients with stable angina in outpatient practice
by: Yu V Luneva, et al.
Published: (2019-08-01)

THERAPY OF STABLE ANGINA OF EFFORT BY TRIPLE COMBINATIONS OF ANTIANGINAL DRUGS IN GERIATRIC PRACTICE
by: S. G. Kanorsky, et al.
Published: (2017-11-01)

Influence of manual thrombus aspiration on left ventricular diastolic function in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
by: Ilić Ivan, et al.
Published: (2016-01-01)

Severe short-lasting left ventricular dysfunction associated with a respiratory infection
by: Stanković Ivan, et al.
Published: (2019-01-01)

MANAGEMENT OF ANGINA ATTACKS IN HEART FAILURE DUE TO NONCORONARY HEART DISEASE: TRIMETAZIDINE USAGE
by: M. Yu. Sitnikova, et al.
Published: (2015-11-01)

The imPAct of Trimetazidine on MicrOcirculation after Stenting for stable coronary artery disease (PATMOS study)
by: Ivan Ilic, et al.
Published: (2023-06-01)

NEW POSSIBILITIES OF TREATMENT OF PATIENTS WITH ISHEMIC HEART DISEASE AND STABLE ANGINA
by: A. A. SIMAKOV, et al.
Published: (2016-12-01)

COMPARATIVE ASSESSMENT OF LARGE ARTERY ELASTICITY IN PATIENTS WITH STABLE ANGINA RECEIVING METABOLIC THERAPY
by: O. V. Ilukhin, et al.
Published: (2012-02-01)

The increased main branch to stent diameter ratio is associated with side branch decreased coronary flow in "true" coronary artery bifurcations treated by "provisional" stenting - a two-dimensional quantitative coronary angiography study
by: Ilić Ivan, et al.
Published: (2020-01-01)

Pharmacotherapeutic approaches targeting stable angina: simple solutions to complex problems
by: Zh. M. Sizova
Published: (2021-04-01)

Efficacy of Trimetazidine in the Prevention of Contrast-Induced Nephropathy in Patients Undergoing Contrast Coronary Intervention: A Systematic Review and Meta-Analysis (PRISMA)
by: Tiny Nair, et al.
Published: (2024-04-01)

The cardioprotective role of trimetazidine on cisplatin-induced cardiotoxicity
by: Murathan Küçük, et al.
Published: (2020-01-01)

Protective Role of Trimetazidine Against Neomycin-induced Hair Cell Damage in Zebrafish
by: Jiwon Chang, et al.
Published: (2013-12-01)

Myocardial metabolic background on chemotherapy and means of their correction
by: Yu. A Vasyuk, et al.
Published: (2013-12-01)

TRimetazidine as an Agent to affeCt clopidogrEl Response: The TRACER Study
by: Naveen Seecheran, et al.
Published: (2019-07-01)

ENDOTHELIAL DYSFUNCTION AND ITS CORRECTION WIT CYTOPROTECTORS IN PATIENTS WITH STABLE EFFORT ANGINA AND ARTERIAL HYPERTENSION
by: F. E. Khlebodarov, et al.
Published: (2009-12-01)

Comparison of Cardioprotective Effects of Dapagliflozin and Trimetazidine in the Model of Doxorubicin-Cyclophosphamide Cardiotoxicity
by: A. A. Avagimyan, et al.
Published: (2023-11-01)

AN EXPERIENCE OF TRIMETAZIDINE USAGE IN COMORBIDITY
by: I. V. Kochetkova, et al.
Published: (2018-04-01)

CARDIOPROTECTION POTENTIAL IN CORONARY HEART DISEASE TREATMENT
by: N. A. Shostak, et al.
Published: (2009-12-01)

Metabolic approach to heart failure: The role of metabolic modulators
by: Giuseppe M.C. Rosano, et al.
Published: (2015-09-01)

Effects of trimetazidine on ventricular remodeling in coronary artery disease patients with left ventricular hypertrophy: the rationale and design of a randomized controlled trial
by: Lili Wu, et al.
Published: (2020-06-01)

The importance of echocardiography in diagnostics of idiopathic pulmonary arterial hypertension: A case report
by: Stojković Gabrijela, et al.
Published: (2011-01-01)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015-12-01)

Trimetazidine ameliorates hindlimb ischaemic damage in type 2 diabetic mice
by: Yan Yang, et al.
Published: (2021-01-01)

Biochemical Aspects That Lead to Abusive Use of Trimetazidine in Performance Athletes: A Mini-Review
by: Amalia Pușcaș, et al.
Published: (2024-01-01)

INFLUENCE OF TRIMETAZIDINE METABOLIC THERAPY ON CONNECTIVE TISSUE METABOLISM IN EXPERIMENTAL DIFFUSE ISCHEMIC NECROTIC CARDIOSCLEROSIS IN RATS WITH DIFFERENT RATES OF HYPOXIA RESISTANCE
by: H. S. Saturska, et al.
Published: (2016-05-01)

RATIONALE FOR APPLICATION, AND BENEFITS OF TRIMETAZIDINE IN HEART FAILURE BY ITS INFLUENCE OF MYOCARDIUM METABOLISM
by: Yu. M. Lopatin, et al.
Published: (2016-08-01)

THE USAGE OF TRIMETAZIDINE IN COMPLEX TREATMENT OF HEART FAILURE
by: N. R. Paleev, et al.
Published: (2001-04-01)

TRIMETAZIDINE INFLUENCE ON FILTRATION AND TUBULOINTERSTITIAL FUNCTION OF KIDNEYS IN ISCHEMIC HEART DISEASE PATIENTS WITH CHRONIC HEART FAILURE AND RENAL DYSFUNCTION
by: N. A. Koziolova, et al.
Published: (2018-03-01)

Trimetazidine offers myocardial protection in elderly coronary artery disease patients undergoing non-cardiac surgery: a randomized, double-blind, placebo-controlled trial
by: Zhong-Liang Dai, et al.
Published: (2021-10-01)

Trimetazidine Prevents Oxidative Changes Induced in a Rat Model of Sporadic Type Of Alzheimer's Disease
by: Gholamreza Hassanzadeh, et al.
Published: (2015-01-01)

Effect of trimetazidine on myocardial salvage index in patients with acute ST segment elevation myocardial infarction undergoing primary PCI
by: Foad Khaled, et al.
Published: (2013-09-01)

Effects of sustained-release trimetazidine on chronically dysfunctional myocardium of ischemic dilated cardiomyopathy – Six months follow-up result
by: A. Momen, et al.
Published: (2016-11-01)

Effects of trimetazidine and perindopril on myocardialfunction and metabolism in postmyocardial infarction patients with cardiac failure
by: A V Shabrov, et al.
Published: (2003-09-01)

Synergistic interaction between trimetazidine and ketoprophen in mice
by: Daniela Carmen Ababei, et al.
Published: (2015-06-01)